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Background. Volatile acetone is a potential biomarker that is elevated in various disease states. Measuring acetone in exhaled
breath is complicated by the fact that the molecule might be present as both monomers and dimers, but in inconsistent ratios.
Ignoring the molecular form leads to incorrect measured concentrations. Our first goal was to evaluate the monomer-dimer ratio
in ambient air, critically ill patients, and rats. Our second goal was to confirm the accuracy of the combined (monomer and dimer)
analysis by comparison to a reference calibration system.Methods. Volatile acetone intensities from exhaled air of ten intubated,
critically ill patients, and ten ventilated Sprague-Dawley rats were recorded using ion-mobility spectrometry. Acetone con-
centrations in ambient air in an intensive care unit and in a laboratory were determined over 24 hours. )e calibration reference
was pure acetone vaporized by a gas generator at concentrations from 5 to 45 ppbv (parts per billion by volume). Results. Acetone
concentrations in ambient laboratory air were only slightly greater (5.6 ppbv; 95% CI 5.1–6.2) than in ambient air in an intensive
care unit (5.1 ppbv; 95%CI 4.4–5.5; p< 0.001). Exhaled acetone concentrations were only slightly greater in rats (10.3 ppbv; 95%CI
9.7–10.9) than in critically ill patients (9.5 ppbv; 95% CI 7.9–11.1; p< 0.001). Vaporization yielded acetone monomers
(1.3–5.3mV) and dimers (1.4–621mV). Acetone concentrations (ppbv) and corresponding acetone monomer and dimer in-
tensities (mV) revealed a high coefficient of determination (R2 � 0.96). )e calibration curve for acetone concentration (ppbv) and
total acetone (monomers added to twice the dimers; mV) was described by the exponential growth 3-parameter model, with an
R2 � 0.98. Conclusion. )e ratio of acetone monomer and dimer is inconsistent and varies in ambient air from place-to-place and
across individual humans and rats. Monomers and dimers must therefore be considered when quantifying acetone. Combining
the two accurately assesses total volatile acetone.
1. Introduction
Acetone is one of the most volatile molecules in human
breath and responsible for the odor of decaying apple in
expired air. Decarboxylation of acetoacetate and oxidation
of isopropanol are the two major physiological sources of
acetone in humans [1]. Acetone is an important physio-
logical marker of lipolysis starvation [2]. It is elevated in
various disease states including diabetes mellitus [3], iso-
propyl-alcohol intoxication [4], ketogenic and Atkins diets
[5], lung tumors [6], and infections [7]. Assessing blood
acetone concentration from exhaled gas might be useful for
clinicians and patients. For example, diabetics might use
expired breath to determine whether they are becoming
ketotic.
Measuring acetone in exhaled air is complicated by the
fact that the molecule might be present as both monomers
and dimers [8], and the relationship is inconsistent. Our first
goal was therefore to evaluate the monomer-dimer ratio in
ambient air of an intensive care unit and a laboratory, as well
as in exhaled breath of critically ill patients and rats.
To the extent that the monomer-dimer ratio varies,
accurate assessment of total acetone in expired breath will
require determining the concentrations of each species and
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adding the monomer concentration to twice the dimer
concentration. Our second goal was thus to confirm that this
combined analysis approach is accurate using a reference
calibration system.
Our study addresses two important issues: (1) simple
quantification of volatile acetone oligomers in exhaled air
using ion-mobility spectrometry and (2) quantification of
accuracy by comparison to values from a calibration gas
generator. Our results will facilitate future investigations of
volatile acetone as a biomarker.
2. Materials and Methods
2.1. Multicapillary Column Ion-Mobility Spectrometry.
Volatile acetone intensities were recorded as described
previously using a MCC-IMS (BreathDiscovery, B&S
Analytik, Dortmund, Germany) [9, 10]. Preseparation of
volatile acetone by multicapillary columns resulted in
compound retention time (RT), analysis by ion-mobility
spectrometry in drift time (1/K0). Acetone monomers and
dimers were identified in the chromatogram by Visual Now
3.6 (B&S Analytik, Dortmund, Germany) and comparison
with an existing database (BS-MCC/IMS-analytes database,
version 1209, B&S Analytik, Dortmund, Germany) [11] as
well as pure substance measurements. Intensity of total
volatile acetone was calculated:
Total acetone intensity (V)� acetone monomer intensity
(V) + (2 ∗ acetone dimer intensity (V)).
2.2. Calibration Gas Generator. Acetone pure substance
(99.9%, Sigma Aldrich, Seelze, Germany) was vaporized at a
relative humidity of 100% and a temperature of 37°C in steps
of 5 ppbv and concentrations ranging from 5 to 45 ppbv using
a calibration gas generator (HovaCAL, Inspire Analytical
Systems, Oberursel, Germany) as previously described [12].
At each concentration, five 10ml gas samples were aspirated
from the calibration gas generator through a polytetra-
fluoroethylene tube (Bohlender, Grünsfeld, Germany). Blank
measurements were interposed between each concentration
step.
2.3. Room Air. Acetone concentrations in ambient air from
an intensive care unit and from a laboratory were deter-
mined using MCC-IMS, each over a period of 24 hours with
a sampling interval of 30 minutes.
2.4. Patients. With approval from the responsible ethics
committee (identification number 232/14, Ärztekammer
Saarland, Saarbrücken, Germany) and in accordance with
the STROBE guidelines, volatile acetone concentrations
were evaluated in ten sedated, intubated, and mechanically
ventilated adults from a surgical intensive care unit. Written
consent was obtained from either patients or legal guardians.
Patients were ventilated with an intensive care respirator
(EVITA 4, Dräger, Lübeck, Germany) with ventilation pa-
rameters and oxygen concentrations adjusted to maintain
physiological blood gas values. A polytetrafluoroethylene
tube was connected near each patient’s endotracheal tube.
10ml mixed inspired and expired gas samples were aspirated
from the breathing circuit at 30-minute intervals for a period
of twelve hours.
2.5. Animals. With authorization by the local agency of
animal protection (approval number 41/2014, Ministerium
für Umwelt und Verbraucherschutz, Saarbrücken, Ger-
many) and in accordance with the German Animal Welfare
Act and ARRIVE guidelines, we studied ten male Sprague-
Dawley rats (200–300 g bodyweight, age 8–10 weeks, Charles
River, Sulzfeld, Germany). Each was anaesthetized, tra-
cheotomized, and ventilated for a period of 24 hours as
described previously [9, 10]. 10ml expired gas samples were
aspirated from the ventilator tubing system through poly-
tetrafluoroethylene tubes every 20min and analyzed using
MCC-IMS [13].
2.6. Statistics. We used SigmaPlot (version 12.5, Systat
Software, Erkrath, Germany) for statistical analyses. )e
correlation between voltages and concentrations was cal-
culated using Pearson correlation. Monomer and dimer
fraction versus concentration in ppbv was plotted on a 3D-
graph. We used t or Mann–Whitney rank sum tests to
compare ambient acetone concentrations from intensive
care unit and laboratory air. To compare patients and rats,
we used one-way ANOVA. A two-tailed p value< 0.05 was
considered statistically significant.
3. Results
Acetone concentration in ambient air was slightly higher in
laboratory (5.6 ppbv; 95% CI 5.1–6.2) than in intensive care
unit (5.1 ppbv; 95% CI 4.4–5.5; p< 0.001). Intensities of
monomers and dimers as well as dimer fraction and con-
centrations of volatile acetone in ambient air are presented
in Table 1.
Exhaled acetone concentration was slightly higher in rats
(10.3 ppbv; 95% CI 9.7–10.9) than in critically ill patients
(9.5 ppbv; 95% CI 7.9–11.1; p< 0.001). Seven patients had
concentrations between 4 and 6 ppbv, whereas three patients
displayed substantially greater concentrations in exhaled air
(8.3, 12.9, and 48.3 ppbv). Dimer fraction was comparable in
the rats (95%, 95% CI 95-96) and critically ill patients (90%,
95% CI 89–91) (Table 1).
Acetone vaporization resulted in 45 data triplets con-
taining concentration (ppbv), monomer intensity (volts),
and dimer intensity (volts). Monomers yielded intensities
from 1.3 to 5.3mV and dimers intensities from 1.4 to
621mV. Calibration curve of acetone concentration (ppbv)
vs. total acetone intensity (mV) fits an exponential growth 3-
parameter model with an R2 � 0.98 (Figure 1).
Correlation analysis of calibration of monomer (mV)
versus dimer (mV) versus concentration (ppbv) revealed the
coefficient of determination of R2 � 0.96 (Figure 2).
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4. Discussion
)e monomer-dimer ratios varied slightly across locations
and in the exhaled breath of critically ill patients and rats.
However, we detected comparable concentrations of volatile
acetone in laboratory and intensive care unit. Dimer fraction
was slightly increased in the intensive care ward without
reaching a statistical significance. )us, concentrations and
the distribution pattern of volatile acetone oligomer vary,
but only to a small extent. Although our results show sig-
nificant differences with narrow confidence intervals be-
tween different environments, these findings are specific for
our building and might be clinical negligible. )ey merely
reflect a snapshot of specific daytime with individual staff
and equipment and might differ at another point in time
limiting our data. )ere are multiple plausible sources of
acetone emission in laboratories including chemical prod-
ucts, cleaning and disinfection solutions, pharmaceuticals,
antiseptics, and the human exhalome [14]. However, almost
identical dimer fractions in ambient air might be the result of
comparable humidity and temperature in laboratory and
intensive care unit.
Acetone concentration in ambient air can be rapidly
determined using MCC-IMS but might be dependent on
numerous influencing factors. Confirming our results,
Bessonneau et al. reported widely variable acetone con-
centrations between different sampling sites in hospital
using gas chromatography-mass spectrometry. In addition,
they observed a significant temporal variability in concen-
trations levels of acetone due to multiples sources of
emissions [14]. Compared to public building and private
houses, hospital showed higher acetone concentrations in
ambient air [15].
We demonstrated substantial higher expired acetone
concentrations in rats compared to ventilated critically ill
patients. Dimer fractions were similar in both groups but
almost twice as high as in ambient air. Our data indicate
narrow confidence intervals for the most standardized
model in rats, receiving a continuous glucose solution and
slightly greater interindividual variability in ventilated pa-
tients suggesting numerous influencing factors during
critical illness. Nevertheless, critically ill patients are nour-
ished artificial. Continuous supply via the gastric tube
provides sufficient energy intake preventing marked keto-
genesis and acetone production [16]. However, interindi-
vidual variability in exhaled acetone might be caused by
Table 1: Monomer, dimer, and total acetone intensity (mV).
Intensity (mV)
Dimer (%) Concentration (ppbv)Monomer Dimer Total
Intensive care unit 40 (37–46) 22 (18–27) 84 (70–97) 48 (46–50) 5.1 (4.4–5.5)
Laboratory 74 (52–96) 21 (17–25) 116 (88–144) 44 (39–48) 5.6 (5.1–6.2)#
Critically ill patients 15 (12–18)∗ 106 (85–126)∗ 226 (185–268)∗ 90 (89–91) 9.5 (7.9–11.1)∗
Rats 6 (6-6)∗ 127 (118–135)∗ 259 (241–276)∗ 95 (95-96) 10.3 (9.7–10.9)∗
Monomer, dimer, and total acetone intensity ((mV); total acetone intensity (mV)� acetone monomer intensity (mV) + (2∗ acetone dimer intensity (mV))),
dimer peak fraction of total acetone peak intensity, and concentrations (ppbv) in ambient air of intensive care unit, laboratory, critically ill patients, and rats.
Data are expressed as means (95% CI); #p< 0.001 significant higher concentration of volatile acetone in laboratory vs. intensive care unit (Mann–Whitney
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Figure 1: Calibration curve of acetone concentration (ppbv) vs.
acetone monomer and 2∗ acetone dimer (mV); R2 � 0.98. Acetone
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Figure 2: Acetone concentrations (ppbv) and corresponding acetone
monomer and dimer intensities (mV) measured by MCC-IMS;
R2� 0.96. Acetone concentration (ppbv)� 8.41–2928∗ acetone
monomer intensity (mV)+ 74∗ acetone dimer intensity (mV).
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postaggression syndrome, increased lipolysis, and accu-
mulation of fatty acids and ketones during critical illness.
We were able to show that volatile acetone concentrations
differ in expired air of various subjects. Additionally, MCC-
IMS enables sufficient quantification of acetone even in
humid expired air.
)ere is widespread evidence for the correlation between
blood glucose levels and exhaled acetone concentrations in
critically ill patients [17]. Acetone derives from acetoacetate
and degradation of ketone bodies explaining these findings
[18]. However, large variation in expired acetone levels in
critically ill patients has been described before [19–21],
limiting the accuracy of acetone as a marker for blood
glucose prediction in critical care medicine. Furthermore,
coexisting diabetes mellitus [3] and infections [7] during
critical illness influence the acetone metabolism and result in
unpredictable expired acetone concentrations. )is might
explain findings of Scholpp and colleagues, detecting
comparable exhaled acetone concentrations between healthy
volunteers and critically ill, mechanically ventilated patients
[22]. In contrast to humans, we demonstrated in a previous
study, a poor correlation between volatile acetone and blood
glucose levels in rats but a trend toward lower acetone
concentrations with the cumulative input of glucose [23].
However, differences in exhaled acetone concentrations
between critically ill patients and rats are speculative and
might depend on several influencing factors.
Different subjects showed various distribution patterns
of acetone monomer and dimer. Variations were significant
between groups with relatively narrow confidence intervals
in the highly standardized rat model but greater spread
among the inhomogeneous group of patients. Usually,
breathing tubes of ventilated patients were connected to a
heat-and-moisture exchanging filter. )is results in in-
creased humidity and higher temperature of inspired air.
)us, higher fraction of acetone monomer is the conse-
quence explaining our findings. Compared to this, rats were
ventilated without breathing filters. )erefore, lower tem-
perature and less humidity of inhaled air are responsible for
higher dimer fraction. Furthermore, it can be expected that
oxygen and nitrogen content, respectively, might influence
acetone monomer and dimer formation as well; the higher
humidity of oxygen compared to nitrogen accelerates the
formation of acetone water clusters, so less dimer is observed
using higher oxygen fractions. In our study, we ventilated
rats with 21% oxygen. Usually, critically ill patients need
higher oxygen fractions explaining our findings. It is ap-
parent from our results that the condition of inspired air
contributes to a considerable extent to the distribution
pattern of monomer and dimer in expired air. Consequently,
monomer formation might have a significant impact in
breath gas analysis of ventilated critically ill patients.
Acetone monomer and dimer have a significant impact
on total acetone concentration. We demonstrated a sub-
stantial correlation between monomer, dimer, and acetone
concentrations exhibiting a high coefficient of determina-
tion. Considering total acetone intensity consisting of
monomer and double dimer intensity correlation yielded
even superior dependency. Ratio of monomer to dimer
formation depends on several influencing factors: high
concentration [24, 25], low humidity [26], and low tem-
perature [27] result in increased dimer formation. Forma-
tion of protonated dimer could be observed for several
volatile compounds, depending on further physicochemical
properties that are not completely understood and pre-
dictable [26]. Acetone dimer can be expected to be a proton
bound, two-fold ionic complex [28]. However, the pro-
tonation leads to higher carbonyl activity side reactions such
as aldol addition and even aldol condensation can occur.
Nevertheless, it has been proven (with ab initio calculations
and semiempirically) that the most likely and most stable
isomer is the proton bound dimer [29]. Acetone is known to
have a higher proton affinity (812 kJ/mol) compared to water
(697 kJ/mol). )erefore, acetone can be detected with great
sensitivity using the atmospheric pressure chemical ioni-
zation process in MCC-IMS [30].
Although higher protonated oligomers of acetone are
theoretically possible, we did not observe higher oligomers
than the dimer. Presumably, the acetone dimer water
clusters are stable at given conditions and atmospheric
pressure. Due to short time being ionized, not even the next
higher oligomer, the acetone trimer, can be formed in a
measurable amount for our given method. It is apparent
from our results that MCC-IMS is suitable for bedside and
near real-time quantification of volatile acetone even in
exhaled humid breath on condition that monomer is not
neglected. Real-time measurement and low-instrumental
requirement (atmospheric pressure) of MCC-IMS is a huge
advantage against the gold standard method gas chroma-
tography-mass spectrometry for quantification of acetone in
human breath. Latter needs a vacuum where molecules get
ionized. At this, protonated acetone molecules have less time
to form dimers and undergo side reactions caused by short
lifespan after ionization in vacuum. Signals of dimer and
potential isomers are much smaller using gas chromatog-
raphy-mass spectrometry. Furthermore, since proton bound
dimer and aldol adduct have the same m/z� 117 and the
same retention time, it is challenging to separate those two
species using gas chromatography-mass spectrometry, since
they can only be formed after ionization and therefore have
same retention times.
We selected MCC-IMS for quantification of volatile
acetone and analysis of expired air in both, humans and rats.
Advantages compared to other technologies include bedside
online-measurements with near real-time data acquisition,
low technical and financial expenditure, and high sensitivity
with detection limit down to the ng L−1 and pg L−1 range
[31]. Direct investigation of humid exhaled air, minimal
weight, size, and power consumption, and no required
vacuum are major benefits of this technology over gas
chromatography-mass spectrometry. )is approach enables
serial bedside measurements even on the intensive care ward
and during long-term measurements in ventilated rats [10].
MCC-IMS provides intensities (millivolt) as a surrogate of
quantity rather than concentrations, but calibration reveals
an excellent correlation between monomer, dimer, and
acetone concentration with a high coefficient of
determination.
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)e acetone concentrations we observed in ambient and
expired air are specific for our setting and will presumably
differ at least somewhat in other settings. It can be assumed
that especially critically ill patients exhibit numerous
influencing and contributing factors in quantification of
volatile acetone. )us, comparing concentrations of expired
acetone between different subjects must be performed with
caution. Second, we conducted gas sampling in mixed, in-
spired, and expired air of the tubing system of ventilated
humans and rats. Alveolar sampling during expirationmight
result in considerable higher intensities, higher concentra-
tions, and more reliable results. )erefore, comparing our
results to other studies might be challenging. Indeed, other
authors reported higher concentrations of expired acetone
[19–21]. )ird, outlined calibration curves and correlations
between acetone monomer and dimer are specific for our
individual device and not transferable in general. Other
devices require individual calibration. Different circum-
stances with divergent humidity, temperature, and gas
composition might reveal different findings. And finally, it
remains unclear to what extent dimers are formed during
ionization in the IMS device and to what extent endogenous
dimers contribute to this. Nevertheless, we were able to show
that oligomers are sufficiently quantifiable using IMS re-
gardless of their origin.
5. Conclusions
In summary, acetone may be a clinically meaningful bio-
marker. However, the ratio of acetone monomer and dimer
is inconsistent and varies (slightly) in ambient air from
place-to-place and across individual humans and rats.
Monomers and dimers must therefore be considered when
quantifying volatile acetone. Ion-mobility spectrometry
combines monomers and dimers in the analysis, and precise
measurements require that each be quantified.
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